DIRECT BINDING OF FOLLISTATIN TO A COMPLEX OF BONE-MORPHOGENETIC PROTEIN AND ITS RECEPTOR INHIBITS VENTRAL AND EPIDERMAL-CELL FATES IN EARLY XENOPUS EMBRYO

Citation
S. Iemura et al., DIRECT BINDING OF FOLLISTATIN TO A COMPLEX OF BONE-MORPHOGENETIC PROTEIN AND ITS RECEPTOR INHIBITS VENTRAL AND EPIDERMAL-CELL FATES IN EARLY XENOPUS EMBRYO, Proceedings of the National Academy of Sciences of the United Statesof America, 95(16), 1998, pp. 9337-9342
Citations number
38
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
95
Issue
16
Year of publication
1998
Pages
9337 - 9342
Database
ISI
SICI code
0027-8424(1998)95:16<9337:DBOFTA>2.0.ZU;2-3
Abstract
In early development of Xenopus laevis, it is known that activities of polypeptide growth factors are negatively regulated by their binding proteins, In this study, follistatin, originally known as an activin-b inding protein, was shown to inhibit all aspects of bone morphogenetic protein (BMP) activity in early Xenopus embryos. Furthermore, using a surface plasmon resonance biosensor, we demonstrated that follistatin can directly interact with multiple BMPs at significantly high affini ties. Interestingly, follistatin was found to be noncompetitive with t he BMP receptor for ligand binding and to form a trimeric complex with BMP and its receptor. The results suggest that follistatin acts as an organizer factor in early amphibian embryogenesis by inhibiting BMP a ctivities by a different mechanism from that used by chordin and noggi n.